SMS PHARMACEUTICALS
|
The Current P/E Ratio of SMS PHARMACEUTICALS is 39.30.
Share Price | ₹292.5 | Oct 16,2025 |
Market Cap | ₹2,740.7 Cr | |
Earnings-TTM | ₹69.7 Cr | TTM-Consolidated Results |
Price/Earnings | 39.30x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SMS PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,740.7 Cr] as on Oct 16,2025
(/) Earnings [ ₹69.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 39.30x ]
Thus, for SMS PHARMACEUTICALS , the investors are currently willing to pay 39.30 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SMS PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SMS PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SMS PHARMACEUTICALS
PE Ratio Performance Analysis for SMS PHARMACEUTICALS
- SMS PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 17.42x.
- SMS PHARMACEUTICALS 's operated at median p/e ratio of 16.84x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SMS PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 30.25x.
- SMS PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SMS PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SMS PHARMACEUTICALS | 69.74 | 39.30 | 2,740.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.25 | 398,218.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 75.96 | 175,158.0 |
CIPLA LTD | 5,406.81 | 23.44 | 126,710.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 59.73 | 119,586.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.07 | 103,496.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.17 | 101,320.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.35 | 99,013.4 |
LUPIN LTD | 3,722.18 | 23.94 | 89,093.5 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.79 | 64,222.1 |
ABBOTT INDIA LTD | 1,452.29 | 43.65 | 63,398.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SMS PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.07x |
Max industry PE | 75.96x |
Median industry PE | 38.25x |
Average industry PE | 37.79x |
You may also like the below Video Courses